1. Home
  2. ALKS vs AQN Comparison

ALKS vs AQN Comparison

Compare ALKS & AQN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALKS
  • AQN
  • Stock Information
  • Founded
  • ALKS 1987
  • AQN 1988
  • Country
  • ALKS Ireland
  • AQN Canada
  • Employees
  • ALKS N/A
  • AQN N/A
  • Industry
  • ALKS Biotechnology: Pharmaceutical Preparations
  • AQN Electric Utilities: Central
  • Sector
  • ALKS Health Care
  • AQN Utilities
  • Exchange
  • ALKS Nasdaq
  • AQN Nasdaq
  • Market Cap
  • ALKS 4.8B
  • AQN 4.0B
  • IPO Year
  • ALKS 1991
  • AQN 1998
  • Fundamental
  • Price
  • ALKS $27.69
  • AQN $4.77
  • Analyst Decision
  • ALKS Buy
  • AQN Hold
  • Analyst Count
  • ALKS 12
  • AQN 7
  • Target Price
  • ALKS $35.42
  • AQN $6.04
  • AVG Volume (30 Days)
  • ALKS 1.9M
  • AQN 5.6M
  • Earning Date
  • ALKS 10-24-2024
  • AQN 11-07-2024
  • Dividend Yield
  • ALKS N/A
  • AQN 8.33%
  • EPS Growth
  • ALKS 55.25
  • AQN N/A
  • EPS
  • ALKS 1.97
  • AQN N/A
  • Revenue
  • ALKS $1,505,121,000.00
  • AQN $2,614,452,000.00
  • Revenue This Year
  • ALKS N/A
  • AQN N/A
  • Revenue Next Year
  • ALKS N/A
  • AQN N/A
  • P/E Ratio
  • ALKS $14.17
  • AQN N/A
  • Revenue Growth
  • ALKS N/A
  • AQN 1.88
  • 52 Week Low
  • ALKS $22.22
  • AQN $4.67
  • 52 Week High
  • ALKS $32.88
  • AQN $6.79
  • Technical
  • Relative Strength Index (RSI)
  • ALKS 50.45
  • AQN 36.05
  • Support Level
  • ALKS $27.11
  • AQN $4.72
  • Resistance Level
  • ALKS $28.29
  • AQN $4.89
  • Average True Range (ATR)
  • ALKS 0.87
  • AQN 0.12
  • MACD
  • ALKS -0.07
  • AQN 0.01
  • Stochastic Oscillator
  • ALKS 45.42
  • AQN 8.94

About ALKS Alkermes plc

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.

About AQN Algonquin Power & Utilities Corp.

Algonquin Power & Utilities Corp, a parent company of Liberty, is a diversified international generation, transmission, and distribution utility with over $16 billion of total assets. Through its two business groups, the Regulated Services Group and the Renewable Energy Group, AQN is committed to providing safe, secure, reliable, cost-effective, and sustainable energy and water solutions through its portfolio of electric generation, transmission, and distribution utility investments to over one million customer connections, largely in the United States and Canada. AQN provides renewable energy through its portfolio of long-term contracted wind, solar, and hydroelectric generating facilities.

Share on Social Networks: